Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Specific Biologics Logo
Specific Biologics Growth Score
64
CB Rank
79687
Heat Score
73
Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
Founded
obfuscation
PrivateGrant Toronto, Ontario, Canada1-10 specificbiologics.com/
Biotechnology
Overview

Specific Biologics
Total Funding
obfuscation
Growth Score
64
Heat Score
73

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score64
-5 pts
in past quarter
Heat Score 73
38 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Specific Biologics

CB Rank
79687
Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
Founded
obfuscation
PrivateGrant Toronto, Ontario, Canada1-10 specificbiologics.com/
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

  • Photo of Odi Israel
    Odi Israel: Co-Founder & Chief Operating Officer
    Past Role: CCRM, Project Management Consultant
  • Photo of Brent Stead
    Brent Stead: CEO & Co-Founder
    Past Role: Therapure Biopharma, Business Development Manager

Details

Legal Name Specific Biologics Inc.
Operating Status Active
Company Type For Profit
Founders  Brent Stead, Odi Israel
About the Company
Specific Biologics is developing a platform technology consisting of a dual-cleaving nuclease that can be safely delivered to cells for the treatment of various genetic diseases. It designed to exploit the cell's naturally occurring DNA repair pathways through enhanced repair or predictable deletions.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Dualase
A gene editing platform technology that cuts DNA twice, creating non-compatible DNA ends to influence cellular DNA repair mechanisms.

Research & Development

Specific Biologics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant
obfuscation
Grant - Specific Biologics Logo
Grant - Specific Biologics
2
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Genome Canada Logo
Genome Canada
—
Grant - Specific Biologics Logo
Grant - Specific Biologics
—
Genome Canada Logo
Genome Canada
—
Grant - Specific Biologics Logo
Grant - Specific Biologics
—
Genome Canada Logo
Genome Canada
—
Grant - Specific Biologics Logo
Grant - Specific Biologics
—
Genome Canada Logo
Genome Canada
—
Grant - Specific Biologics Logo
Grant - Specific Biologics
—
Genome Canada Logo
Genome Canada
—
Grant - Specific Biologics Logo
Grant - Specific Biologics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 1 Contacts 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Dec 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 11, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 11, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

183
-85.01%
 in past month

IT Spend

$132.9KThis year, Specific Biologics is projected to spend $132.9K on IT, according to Aberdeen.

Active Website Tech Count

2Specific Biologics is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 10m.

Total IP

12The intellectual property of Specific Biologics includes 6 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Specific Biologics has registered 6 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Specific Biologics's headquarters? Specific Biologics is located in Toronto, Ontario, Canada.Who invested in Specific Biologics? Specific Biologics has 5 investors including Genome Canada and  Ontario Genomics.When was the last funding round for Specific Biologics? Specific Biologics closed its last funding round on
obfuscation
from a Grant round.Who are Specific Biologics's competitors? Alternatives and possible competitors to Specific Biologics may include Scribe Therapeutics, Tessera Therapeutics, and  Metagenomi.How much funding has Specific Biologics raised to date? Specific Biologics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|